SERUM LEPTIN LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE
AbstractBackground: Cardiovascular diseases (CVD) are the leading cause of morbidity, mortality anddisability worldwide. Leptin, a 16kDa product of ob gene, is an endocrine hormone produced by whiteadipose tissue. It is primarily involved in the regulation of food intake and energy expenditure.Hyperleptinemia is one of the novel risk factors contributing in many ways to CVD. Objective: Theobjective of the study was to find the level of leptin in patients with coronary artery disease (CAD) andcompare it with healthy people in our population. Methods: Our study was an analytical and crosssectional study. Our study included 60 patients with a history of CAD and 60 healthy controls (aged40–60 years, both sexes). Leptin levels were measured by ELISA. Results: Mean serum leptin level inpatients was 11.48±11.25 ηg/ml, while control group had a mean leptin level of 8.22±8.01 ηg/ml(p=0.071). Conclusion: Leptin levels were higher in patients but the difference was non-significant.More studies are needed with larger sample size in our population.Keywords: Coronary Artery Disease (CAD), Leptin
Hajilooi M, Sanati A, Ahmadieh A, Ghofraniha A, Massoud A.
Circulating ICAM-1, VCAM-1, E-Selectin, P-Selectin, and
TNFRII in patients with coronary artery disease. Immunol Invest
Hatmi ZN, Tahvildari S, Motlag AG, Kashani AS. Prevalence of
coronary artery disease risk factors in Iran: a population based
survey. BMC Cardiovasc Disord 2007;7:32.
Haidari M, Javaidi E, Sanati A, Hajilooi M, Ghanbili J.
Evaluation of C-reactive protein, a sensitive marker of
inflammation, as a risk factor for stable coronary artery disease.
Clin Biochem 2001;34(4):309–15.
Zhang Y, Proenca R, Maffei M. Positional cloning of the mouse
obese gene and its human homologue. Nature 1994;372:425–32.
Friedman JM, Leibel RL, Siegel DS, Walsh J, Bahary N.
Molecular mapping of the mouse ob mutation. Genomics
Geffroy S, DeVos P, Staels B, Duban B, Auwerx J, de
Martinville B. Localization of the human OB gene (OBS) to
chromosome 7q32 by fluorescence in situ hybridization.
Moran O, Philip M. Leptin: Obesity, diabetes and other
peripheral effects —a review. Pediatr Diabetes 2003;4(2):101–9.
Meier U, Gressner AM. Chemical Aspects of Leptin, Ghrelin,
Adiponectin, and Resistin. Clin Chem 2004;50:1511–25.
Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM,
Clawson DK et al. Crystal structure of the obese protein leptinE100. Nature 1997;387(6629):206–9.
Koh KK, Park SM, Quon MJ. Leptin and Cardiovascular
Disease: Response to Therapeutic Interventions. Circulation
Paracchini V, Pedotti P, Taioli E. Genetics of Leptin and Obesity:
A HuGE Review. Am J Epidemiol 2005;162(2):101–14.
Ren J. Leptin and hyperleptinemia –from friend to foe for
cardiovascular function. J Endocrinol 2004;181(1):1–10.
Sweeney G. Leptin signaling. Cellular Signalling 2002;14:655–
Giandomenico G, Dellas C, Czekay R-P, Koschnick S, Loskutoff
DJ. The leptin receptor system of human platelets. J Thromb
Yang R, Barouch LA. Leptin Signaling and Obesity:
Cardiovascular Consequences. Circ Res 2007;101(6):545–59.
Beltowski J. Leptin and Atherosclerosis. Atherosclerosis
Bernabucci U, Basirico L, Lacetera N, Morera P, Ronchi B,
Accorsi PA et al. Photoperiod Affects Gene Expression of Leptin
and Leptin Receptors in Adipose Tissue from Lactating Dairy
Cows. J Dairy Sci 2006;89:4678–86.
Melanson KJ, Mclnnis KJ, Rippe JM, Blackburn G, Wilson PF.
Obesity and cardiovascular disease risk: research update. Cardiol
Hafeezullah, Aslam M. Leptin: fights against obesity! Pak J
Physiol 2006;2(1):54–60. [Review]
Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, Gami AS,
Sert Kuniyoshi FH, Wolk R et al. Relation of increased leptin
concentrations to history of myocardial infarction and stroke in
the United States population. Am J Cardiol 2007;100(2):234–9.
Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Mohieldin M, AlKatari M, Jones AF et al. Serum leptin and its relation to
anthropometric measures of obesity in pre-diabetic Saudis.
Cardiovasc Diabetol 2007; 6:18.
Galluccio E, Piatti P, Citterio L, Lucotti PCG, Setola E, Cassina
L, et al. Hyperinsulinemia and impaired leptin:adiponectin ratio
associate with endothelial nitric oxide synthase (nos3)
polymorphisms in subjects with in-stent restenosis. Am J Physiol
Endocrinol Metab 2008;294:E978–86.
Xia D, Song Y, Li C, Zhang F, Wei M. The change of serum
leptin and its relationship with platelet membrane glycoprotein Ib
in patients with coronary heart disease. Frontiers Med China
Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al
Mohammedi H, Al Ozairi ES, et al. Plasma leptin concentration
in patients with Type 2 diabetes: relationship to cardiovascular
disease risk factors and insulin resistance. Diabet Med
Wallace AM, McMahon AD, Packard AJ, Kelly A, Shepherd J,
Gaw A, et al. Plasma leptin and the risk of cardiovascular disease
in the West of Scotland Coronary Prevention Study
(WOSCOPS). Circulation 2001;104:3052–56.
Taneli F, Yegane S, Ulman C, Tikiz H, Bilge AR, Ari Z, et al.
Increased serum leptin concentrations in patients with chronic
stable angina pectoris and ST-elevated myocardial infarction.
Tamer L, Ercan B, Unlu A, Sucu N, Pekdemir H, Eskandari G, et
al. The relationship between leptin and lipids in atherosclerosis.
Indian Heart J 2002;54:692–6.
Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G,
Asplund K et al. Leptin is associated with increased risk of
myocardial infarction, J Intern Med 1999;246:409–18.
Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S
et al. Elevated serum levels of leptin and soluble leptin receptor
in patients with advanced chronic heart failure. Eur J Heart Fail